| |
|
|
|
|
|
|
|
|
1. |
Record Nr. |
UNISA990002752090203316 |
|
|
Autore |
GOLINELLI, Gaetano M. |
|
|
Titolo |
Struttura e governo dell'impresa : verso la formulazione di un modello quantitativo per l'analisi dei processi di sviluppo / Gaetano M. Golinelli |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
|
|
|
|
ISBN |
|
|
|
|
|
|
Descrizione fisica |
|
|
|
|
|
|
Collana |
|
Collana di studi di tecnica aziendale / Università degli Studi di Roma "La Sapienza", Facoltà di economia e commercio, Istituto di tecnica industriale e commerciale ; 2 |
|
|
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Soggetti |
|
Aziende - Gestione finanziaria |
|
|
|
|
|
|
Collocazione |
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
|
|
|
|
|
|
|
2. |
Record Nr. |
UNINA9910138822003321 |
|
|
Titolo |
Berichte der Schweizerischen Botanischen Gesellschaft = : Bulletin de la Société botanique suisse |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Basel, : In Commission bei H. Georg, 1891-[1980] |
|
|
|
|
|
|
|
Descrizione fisica |
|
|
|
|
|
|
Soggetti |
|
Botany |
Botany - Switzerland |
Plants - Switzerland |
Plants |
Periodicals. |
Switzerland |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Periodico |
|
|
|
|
|
|
|
|
|
|
|
|
3. |
Record Nr. |
UNINA9910969632203321 |
|
|
Autore |
Kitchen Steve (Scientist) |
|
|
Titolo |
Quality in laboratory hemostasis and thrombosis / / Steve Kitchen, John D. Olson, F. Eric Preston |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Chichester, West Sussex ; ; Hoboken, NJ, : Wiley-Blackwell, 2009 |
|
|
|
|
|
|
|
ISBN |
|
1-4443-6059-0 |
1-282-00763-7 |
9786612007637 |
1-4443-0357-0 |
1-4443-0358-9 |
|
|
|
|
|
|
|
|
Edizione |
[1st ed.] |
|
|
|
|
|
Descrizione fisica |
|
1 online resource (227 p.) |
|
|
|
|
|
|
Altri autori (Persone) |
|
OlsonJohn David <1944-> |
PrestonF. E |
|
|
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Soggetti |
|
Blood coagulation disorders - Diagnosis |
Blood - Analysis |
Hemostasis |
Thrombosis |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
Description based upon print version of record. |
|
|
|
|
|
|
Nota di bibliografia |
|
Includes bibliographical references and index. |
|
|
|
|
|
|
Nota di contenuto |
|
Contents; Contributors; Foreword; Preface; 1: General quality planning in the hemostasis laboratory; 2: Hemostasis test validation, performance and reference intervals; 3: International Standards in hemostasis; 4: Sample integrity and preanalytical variables; 5: Internal quality control in the hemostasis laboratory; 6: External quality assessment in hemostasis: its importance and significance; 7: Initial evaluation of hemostasis: reagent and method selection; 8: Point-of-care testing in hemostasis; 9: Assay of factor VIII and other clotting factors |
10: Application of molecular genetics to the investigation of inherited bleeding disorders11: Standardization of D-dimer testing; 12: Diagnostic assessment of platelet function; 13: Laboratory evaluation of von Willebrand disease: phenotypic analysis; 14: Laboratory analysis of von Willebrand disease: molecular analysis; 15: Dilemmas in heritable thrombophilia testing; 16: Evaluation of antiphospholipid antibodies; |
|
|
|
|
|
|
|
|
|
|
|
17: Monitoring heparin therapy; 18: Monitoring oral anticoagulant therapy; 19: Monitoring new anticoagulants; 20: Detecting and quantifying functional inhibitors in hemostasis |
Index |
|
|
|
|
|
|
Sommario/riassunto |
|
""Over the last decades, major progress has been made in quality assurance of hemostatic laboratory assays. This book will be an indispensable part of every hemostasis laboratory, where, given its hands-on nature, it will rarely sit to get dusty on the shelves.""-Frits R. Rosendaal, Leiden University Medical Center The hemostasis laboratory has a vital role in the diagnosis and management of patients with familial and acquired hemorrhagic and thrombotic disorders. Its role in the monitoring traditional anticoagulant therapy as well as therapy using new anticoagulants presents |
|
|
|
|
|
|
|
| |